Consultation on proposed ACL divestiture remedy

accc
Written By Julie Clarke

The ACCC is seeking views on a proposed divestiture remedy offered by Australian Clinical Labs Ltd in relation to its proposed acquisition of Healius.

This follows publication by the ACCC of a statement of issues in July 2023, identifying preliminary competition concerns relating to the Australian pathology services market.

View media release.

View merger register.

Julie Clarke
Previous

Consultation paper on Merger Reform
Next

ACCC raises concerns with proposed hotel acquisition